Pharmaceutical & MedTech Business Development & Licensing

Transforming Patient Outcomes

We specialize in creating pathways that bring innovative treatments to patients who need them most

💊 Rare Disease Access

Navigating the complex landscape of orphan drug development and commercialization to ensure life-changing therapies reach patients with rare conditions. We've facilitated access to treatments for over 15 rare diseases affecting pediatric and adult populations.

🎗️ Oncology Innovation

Accelerating the development and commercialization of novel oncology therapies through strategic partnerships. Our work has helped bring 8 innovative cancer treatments to market, improving survival rates and quality of life for thousands of patients.

⚕️ Specialty Medicine Pathways

Creating sustainable models for complex specialty medications that require specialized distribution, reimbursement strategies, and patient support programs. We've established successful market access for 12+ specialty products in challenging therapeutic areas.

In- & Out-Licensing Strategy

We develop comprehensive licensing strategies that maximize the potential of innovative assets while ensuring they reach patients efficiently. Our approach includes:

Global licensing opportunity assessment
Deal structuring for optimal patient access
Risk-sharing models for novel therapies
Pediatric and orphan drug licensing expertise

Patient Impact: Reduced time-to-market by 40% for critical therapies in rare diseases through optimized licensing strategies.

Licensing Strategy Visualization

Partnering and M&A Advisory

Strategic partnerships that accelerate development and expand global reach for breakthrough medicines:

Co-development partnerships for complex therapies
M&A strategies focused on pipeline enhancement
Joint venture formation for market expansion
Due diligence with patient access focus

Patient Impact: Enabled 3 oncology biotechs to secure partnerships that accelerated clinical development by 2+ years.

Partnership Visualization

Market Access Strategy

Creating sustainable access models for innovative therapies in challenging reimbursement environments:

Value-based pricing strategies
Orphan drug and rare disease pricing models
Risk-sharing agreements with payers
Patient assistance program design

Patient Impact: Secured reimbursement in 15+ countries for a novel rare disease therapy within 6 months of approval.

Market Access Visualization

Due Diligence & Valuation

Comprehensive assessment with focus on patient benefit and market potential:

Therapeutic area market analysis
Patient population and unmet need assessment
Clinical and regulatory pathway evaluation
Commercial potential for specialty medicines

Patient Impact: Identified and validated 3 breakthrough oncology assets that received accelerated approval pathways.

Due Diligence Visualization

Case Study: Accelerating Rare Disease Treatment Access

How we helped a biotech company secure global partnerships for a novel gene therapy targeting a rare pediatric neurological disorder

$320M

Total Deal Value

Countries with Access

2,500+

Patients Reached

40%

Faster to Market

"AMG's strategic guidance enabled us to navigate complex licensing negotiations while maintaining our focus on patient access. Their expertise in rare disease markets was instrumental in securing partnerships that will bring our therapy to children worldwide."

— CEO, Pediatric Neurology Biotech